August 23, 2022
A key health ministry advisory committee will discuss whether to grant special approval for AstraZeneca’s long-acting COVID-19 antibody cocktail AZD7442, known as Evusheld overseas, at its meeting on August 29. The Ministry of Health, Labor and Welfare (MHLW) added AZD7442,...read more